Effect of hydroxyurea on thalassemia major and thalassemia intermedia in iranian patients

Pakistan Journal of Medical Sciences

Volumn 25, Issue 1, 2009, Pages 74-78

  Kosaryan, Mehrnoosh ^a,b   Vahidshahi, Koorosh ^b   Karami, Hosein ^b   Ehteshami, Sara ^c  

^a Pediatric Department   (Iran)

^b Dept of Pediatrics ^*  (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hydroxyurea; Iran; Thalassemia intermedia; Thalassemia major

Indexed keywords

HEMOGLOBIN; HYDROXYUREA; SYREA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL LABORATORY; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DESCRIPTIVE RESEARCH; DRUG DOSE INCREASE; DRUG EFFECT; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART PALPITATION; HEMOGLOBIN DETERMINATION; HUMAN; IRAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA; PATIENT COMPLIANCE; SIDE EFFECT; THALASSEMIA; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR; TREATMENT DURATION;

EID: 62549092722     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. United Kingdom Thalassemia Society. Standards for the clinical care of children and adults with thalassemia in the UK. London 2005(ISBN 1 90025 4 18 2)
2. Olivieri NF, Rees D, Ginder GD, Thein SL, Brittenham GM, Waye JS, et al. Treatment of thalassemia major with phenylbutyrate and Hydroxyurea. Lancet 1997;350:491-2.
3. Olivieri NF. Reactivation of fetal hemoglobin in patients with β-thalassemia. Seminars in Hematology 1996;1:24-42.
4. Pace BS, White GL, Dover GJ, Boosalis MS, Faller DV, Perrin SP. Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. Blood 2002;100(13):4640-8.
5. Perrine SP. Fetal globin induction - Can it cure â thalassemia? Hematology 2005;1(38).
6. Hajjar FM, Peason HA. Pharmacologic treatment of thalassemia intermediate with hydroxyurea. J Pediatr 1994;125:490-2.
7. Arruda VR, Lima CA. Successful use of Hydroxyurea in beta thalassemia major [letter] New Eng J Med 1997;13:964.
8. Kosaryan M, Yousefy Gh, Mahdavi MR, Vallaii N, Farzin D. The clinical trial of Hydroxyurea in beta thalassemia intermedia. The 7th international conference on thalassemia and hemoglobinopathies. Thailand 1999. abstract 260
9. Karimi M, Darzi H, Yavarian M. Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. J Pediatric Hematology / Oncology 2005;27(7):380.
10. Saxon BR, Rees D, Olivieri NF. Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during Hydroxyurea therapy in β thalassemia. Brit J Haematology 1998;101:416-9.
11. Cairo H, Wegener M, Debatin KM, Kohne E. Treatment with hydroxyurea in thalassemia intermediate with paravertebral pseudo tumors of extramedullary hematopoiesis Ann Hematol 2002;81(8):478-82.
12. Castelli R, Graziadei G, Karimi M, Capellini MD. Intrathoracic masses due to extramedullary hematopoiesis. Am J Med Sci 2004;328(5):299-303.
13. Vicari P, Figueiredo MS. Regression of extramedullary hematopoiesis with hydroxyurea therapy in beta thalassemia intermediate. Rev Bios Hemotol 2006;28(1):71-2.
14. Perrin SP, Castaneda SA, Boosalis M S, White GL, Jones GS. Induction of fetal globin in beta-thalassemia: Cellular obstacle and molecular progress. Ann NY Acad Sci 2005;1054(1):257-65.
15. Premardhena A, Fisher CA, Olivieri NF, Silva S, Sloane-Stanley J, Wood WG, et al. A novel molecular basis for thalassemia intermedia poses new questions about its pathophisiology. Blood 2005;106(9):3251-5.
16. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Growth impairment in beta-thalassemia major: the role of trace element deficiency and other potential factors. J Pediatr Hematol Oncol 2007;29(1):5-8.
17. Akbari MT, Izadi P, Dudman E. M; Molecular Screening and prenatal diagnosis of a thalassemia in Iran. The 7th international conference on thalassemia and the hemoglobino pathies. Thailand 1999.
18. Kosaryan M, Mojtahedzadeh F, Akhavan Niaki H. The Relationship of XMN1 genotype with response to hydroxyurea in beta thalassemia. In: The 9th international conference in thalassemia and hemoglobinopathies.2003. Italy. poster (www.mazums.ac.ir)
19. Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil J-A, de Montalembert M. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. Transfusion 2007;47(10);1830-36.
20. Kosaryan M, Mojtahedzadeh F, Vahid Shahi K. The bone density of thalassemic patients of Boo Ali Sina, Sari, Iran in 2002. Does Hydroxyurea help? Pediatric Endocrinology Review 2004;2(2):303-6.
21. Rashidi GF, Kosaryan M. Cardiologic evaluation of thalassemic patients while using Hydroxyurea. J Mazandaran Uni Med Sci 2006;51:37-42.